About S2N Health
S2N Health is a private company based in Boston, Massachusetts, incorporated in 2023 in Delaware. It has reported $7,464,787 raised in three offerings on Form D since June 2023. Its chief executive is Amy Siegel.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Jun 2, 2026 | $3,000,000fully sold | 25 | $120K | Debt, Options, Convertible Promissory NotesRule 506(b) | Form D ↗ |
| May 10, 2024 | May 23, 2024amended Jun 5, 2025 | $4,314,787of $6.1M target | 34 | $126K | Equity, Includes conversion of SAFEs.Rule 506(b) | Form D/A ↗1 earlier filing |
| Jun 12, 2023 | Jun 26, 2023 | $150,000of $500K target | 3 | $50,000 | Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $7,464,787 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on S2N Health's Form D filed Jun 2, 2026.
Martha Shadan
Director
RH
Roome Hugh
Director
Andrew Schwab
Managing Partner of Excelerate Health Ventures and director
Also a director at BEKhealth, Huma.AI and Itiliti Health.
